It seems my good news expected for a share price bump may not...

It seems my good news expected for a share price bump may not happen. AccessBio will NOT take up antibody kit and they also will not pay the pay part of the 'take of pay' contract. It seems the contract will morph into 'take or give discount on antigen tests'. The problem there is 'what if Atomo does not get a substantial market of antigen tests... it is quite the crowed market'.

So my whomping big $$$ revenue number to show up on Q1 (ending 30 September) aint gonna show up. I am not sure Mr Market will like to hear 'we will get SOME of the monies of that binding contract sprinkled in the coming Qs'. Because we dont know the sprinkling.

So now the 'good news' I expected will actually be announced as bad news. I sure hope they wrap it up nicely.

And the expected FebriDx FDA approval I can now worry about as it seems the FDA is not so caring about anything 'not covid'. They seem to be on a go slow re all else.

The good news is generally I get my projections back to front. So maybe the above notes are all rubbish. But that is as I think now.